The Washington Post

Redskins’ free agent target Demetress Bell signs with Eagles

The Washington Redskins on Wednesday lost out on another free agent target along the offensive line.

The Philadelphia Eagles announced that they have agreed to a five-year contract with former Buffalo Bills tackle Demetress Bell.

The Redskins had interest in Bell – who previously spelled his name Demetrius, but has since changed it – and had him in for a visit at Redskins Park on March 16.

Bell continued to field inquiries from other teams, and earlier this week visited the Eagles, who earlier this month lost left tackle Jason Peters to a ruptured Achilles’ tendon.

The Redskins entered free agency hoping to address the right tackle position, where Jammal Brown has been hobbled by a bad hip for two straight seasons. They expressed interest in Houston’s Eric Winston, but Winston ended up signing with the Kansas City Chiefs.

The Redskins also had tried to fortify the left guard position, where Kory Lichtensteiger is trying to come back from a torn ACL and MCL that forced him out of the final 1 games of the 2011 season. Washington had interest in guards Ben Grubbs and Evan Mathis, but Grubbs signed with New Orleans, and Mathis re-signed with Philadelphia.

The Redskins re-signed Lichtensteiger, who was a restricted free agent, and Brown and coach Mike Shanahan both said that he is progressing in his rehabilitation. But Washington could both seek to address both positions in the draft.

Mike Jones covers the Washington Redskins for The Washington Post. When not writing about a Redskins development of some kind – which is rare – he can be found screaming and cheering at one of his kids’ softball, baseball, soccer or basketball games.

The Freddie Gray case

Please provide a valid email address.

You’re all set!

Campaign 2016 Email Updates

Please provide a valid email address.

You’re all set!

Get Zika news by email

Please provide a valid email address.

You’re all set!
Show Comments
Most Read



Success! Check your inbox for details.

See all newsletters

Close video player
Now Playing